TriSalus Life Sciences (TLSI) Inventory (2022 - 2026)

TriSalus Life Sciences' Inventory history runs 5 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• On a quarterly basis, Inventory fell 9.23% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 9.23% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, down 23.99% from the prior year.
• Inventory climbed to $3.8 million in Q1 2026 per TLSI's latest filing, from $3.1 million in the prior quarter.
• Across five years, Inventory topped out at $4.2 million in Q1 2025 and bottomed at $1.5 million in Q4 2022.
• The 5-year median for Inventory is $3.4 million (2024), against an average of $3.2 million.
• Across the five-year window, Inventory jumped 145.49% in 2024 and retreated 23.99% in 2025, its largest moves.
• Year by year, Inventory stood at $1.5 million in 2022, then soared by 73.01% to $2.5 million in 2023, then surged by 59.06% to $4.0 million in 2024, then fell by 23.99% to $3.1 million in 2025, then advanced by 22.78% to $3.8 million in 2026.
• Per Business Quant, the three latest TLSI Inventory figures stand at $3.8 million (Q1 2026), $3.1 million (Q4 2025), and $3.3 million (Q3 2025).